Objectives. The aim of this study was to analyse the results of brachiocephalic fistulas for haemodialysis and to determine possible predictors of failure. Patients and methods. Between April 1999 and September 2004, a consecutive series of 100 autologous brachiocephalic fistulas were created in 96 patients. There were 57 men and 39 women with a mean (SD) age of 59.2 (15.6) years. Data were prospectively gathered. Results. The mean (SD) follow-up was 20.1 (16.4) months. The primary, primary assisted, and secondary patency rates after 6 months were 73.4, 83.2 and 86.4%, respectively. After 1 year, these figures were 54.7, 72.3 and 79.2%, and after 2 years 40.4, 59.2 and 67.5%, respectively. Predictors of failure with regard to primary patency, determined with Cox regression multivariate analysis, included diabetes mellitus (HR 2.81, p!0.001) and a history of contralateral PTFE loop graft (HR 7.79, pZ0.007). Conclusion. Primary patency of brachiocephalic fistulas is comparable to that of radiocephalic fistulas. Primary assisted and secondary patency rates can, however, be brought to a much higher level, especially in patients without diabetes and a largediameter venous outflow tract.
In 1997, the National Kidney Foundation-Dialysis Outcome Quality Initiative (DOQI) initiated new clinical practice guidelines aiming to give vascular access decision-making an evidence-based character. 1 One of the guidelines describes the order of preference for the placement of arteriovenous fistulas. It is thought that an autologous fistula performs better than an allograft. The autologous radiocephalic lowerarm fistula was selected as the fistula of choice because of its long-term patency and low complication rate. 2 Second choice according to the DOQI guidelines is the brachiocephalic upper-arm fistula first described by Cascardo et al. in 1970 . 3 The order of preference of these surgical access procedures has been based on several reports with varying patency rates. This raises questions about the estimated patency rates for both radiocephalic and brachiocephalic fistulas. Rooijens et al. 4 reported a meta-analysis of eight prospective and 30 retrospective studies regarding radiocephalic fistulas. The pooled estimated 1-year primary and secondary patency rates of 62.5% and 66.0%, respectively, is disappointing. These relatively low patency rates may be the result of the inclusion of patients with smaller vessels, the elderly, women or diabetics. In certain instances it may, therefore, be wise to choose the brachiocephalic fistula as a first option for permanent surgical access. In this study, we assessed the outcome of a consecutive series of 100 brachiocephalic fistulas and analysed the possible influence of patient-related characteristics on success or failure.
Patients and Methods

Design of the study
This study is a prospective cohort analysis in a singlecentre university teaching hospital of patient related factors influencing the outcome of primary autologous brachiocephalic fistulas. Table 1 .
To define the overall pool of patients undergoing primary access surgery during the same period, data regarding other access options were collected retrospectively from hospital records. In this time period, a total of 129 radiocephalic fistulas in 117 patients (mean age 58.9 (16.0)) and 60 polytetrafluoroethylene (PTFE) grafts, including 55 loops and five straight grafts, in 52 patients (mean age 56.9 (14.5)) were carried out. In addition, two autologous lower arm fistulas using the ulnar artery and two autologous fistulas at the level of the leg were performed. There were no statistical differences with regard to mean age between these various groups.
Preoperatively, both arms were examined with duplex ultrasound scanning. Diameters of the brachial artery and the cephalic vein at the levels of the elbow and upper arm were determined. Duplex diameter measurements took place with a cuff inflated up to 50 mmHg around the proximal upper arm. In addition, the presence of central venous obstructions was assessed. The minimum cephalic vein diameter required was set at 2.5 mm. If technically possible, the non-dominant extremity was used for construction of the fistula.
Timing
Maturation times of 1-4 months must elapse following creation of an autologous fistula before it can be used. 1 The fistula should, therefore, preferably be created several months in advance of the anticipated need for dialysis or an alternative temporary method of vascular access must be used while the fistula develops. As in most of our cases, a brachiocephalic fistula was not the preferred first surgical procedure, 82% were already on dialysis at the time of operation. At that moment, a total of 169 central venous lines had been inserted. Although currently it is our policy to use the internal jugular vein for temporary access in most of the cases, 29 ipsilateral subclavian catheters had been used in 22 patients, while 46 ipsilateral jugular catheters had been inserted in 35 patients. Thirty-five patients had a radiocephalic fistula created previously on the ipsilateral side, while five of them also had a PTFE loop graft on the same side.
Surgical procedure
Operations were performed under general (58% of cases), regional (39%) or local anaesthesia (3%). The choice of anaesthesia was left to the anaesthetist's and patient's preference. A transverse incision was made in the cubital fossa and the median cubital vein, as well as the cephalic and perforating veins, were explored. An end-to-side anastomosis was made with a running polypropylene 6-0 suture between the median cubital vein and the brachial artery, as previously described by Bender et al. 6 The distal and perforating vein branches were ligated directing all flow towards the upper arm cephalic vein. In some cases, an end-to-side anastomosis between the cephalic vein and the brachial artery was created. The length of the anastomosis was chosen to fit the size of the vein, usually 1.5-2 times the vein diameter. Fifty-nine fistulas were created on the left and 41 on the right side. Fistulas were allowed at least 6 weeks to develop before puncture for haemodialysis.
Follow up
Fistulas were checked for patency by clinical judgement during regular visits at the dialysis centre three times a week. Also, ultrasound dilution flow measurements were performed with a Transonic HD01 plus Hemodialysis Monitor (Transonic Systems Inc., Ithaca, NY, USA) on a monthly basis. In addition, Duplex assessment (Sonoline Antares, Siemens Nederland b.v., The Hague, The Netherlands) with a multifrequency probe (VFX 13-5) set at a frequency of 10 MHz was carried out on the day of discharge, and after 3 and 6 months. Patients with repeatedly measured flow rates of less than 600 ml/min or a consistent decrease in time of 40% or more were subjected to further analysis with angiography. Short segment stenoses were subsequently treated with percutaneous transluminal angioplasty (PTA).
Definitions, endpoints, and statistics
Definitions of patency were those recommended by the Committee on Reporting Standards for ArterioVenous Access of the Society for Vascular Surgery and the American Association for Vascular Surgery. 7 All patency rates were calculated by means of KaplanMeier analysis. Primary endpoints were defined as thrombosis or occlusion of the fistula, inadequate maturation, reintervention for assistance or restoration of patency, change to another form of dialysis, renal transplantation, or death of the patient. The influence of 26 patient-related factors was investigated by means of univariate analysis with the use of Kaplan-Meier curves (log-rank test). Continuous variables were transformed into binary variables depending on their median. Variables that had a direct influence after univariate analysis were entered in a stepwise backward manner into a multivariate Cox regression model. Significance was set at p!0.05. Data are presented as means (SD), unless stated otherwise.
Results
Patency rates and mortality
Each patient was followed for at least 3 months. The mean (SD) follow-up was 20.1 (16.4) (range 0.3-66.1) months, including the early drop-outs. Reasons for early failure within 4 months after the initial operation included thrombosis (nZ3), immaturity (nZ5), steal (nZ2), and untreatable stenosis (nZ1). Fistulas of all these patients, including two patients who died with a patent shunt, never came into use. Primary, primary assisted, and secondary patency rates, as estimated by means of Kaplan-Meier analysis, are outlined in Fig. 1 . Primary patency rates were 73.4, 54.7, and 40.4%, after 6 months, 1 and 2 years, respectively.
Primary assisted patency rates after 6 months, 1 and 2 years, were 83.2, 72.3, and 59.2%, respectively. A total of 67 PTA procedures were carried out to maintain fistula function in 28 patients. Fifteen patients had one PTA, six patients had two, two patients had three, and five patients had more than three PTA procedures, up to 11 done in one single patient. In one patient, a successful attempt was made to reduce flow because of steal symptoms by placing a PTFE loop, while in another patient flow was re-directed by ligation of the basilic vein. Other flow reducing salvage procedures, such as DRIL procedure or banding have not been attempted in this study cohort, because of poor results in the past.
Secondary patency rates were 86.4, 79.2, and 67.5%, after 6 months, 1 and 2 years, respectively. A total of 15 surgical revision procedures were performed in 14 patients. All these 15 fistulas had thrombosed and were treated with thrombectomy and subsequent revision of a stenosis with a segment of saphenous vein (nZ5) or excision of the stenosis with construction of a new anastomosis (nZ3), or interposition with saphenous vein (nZ1) or PTFE (nZ6). With regard to secondary patency, 29 fistulas were regarded as permanent failures as secondary patency endpoints were reached. Thirteen of these 29 fistulas had occluded without (another) attempt to salvage the fistula, six failed to mature and in 10 instances the use of the brachiocephalic fistula was discontinued because of steal syndrome (nZ4), venous hypertension (nZ2), fistula malfunction due to inability to puncture appropriately (nZ2) or insufficient run-off with untreatable central venous stenosis (nZ2).
Twenty-one patients died during the study period for various reasons, mostly cardiac related and none of them as the consequence of the primary operation. One patient, however, died 2 h after a surgical revision in the recovery room as a consequence of ventricular fibrillation.
Predictors of failure with regard to primary patency
There were three variables that reached significance as a predictor of failure with regard to primary patency at univariate analysis, namely diabetes mellitus, a history of contralateral PTFE graft and thickness of the suture (Table 2 ). These three variables were all entered in a Cox regression multivariate analysis model. Diabetes (HR 2.81, 95% CI 1.56-5.06, pZ0.0006) and a history of contralateral PTFE (HR 7.79, 95% CI 1.75-34.72, pZ0.007) were subsequently identified as independent predictors of failure.
Predictors of failure with regard to primary assisted patency
With regard to primary assisted patency, the same variables were assessed (Table 2) . Diabetes mellitus, a history of ipsilateral jugular catheter, a history of contralateral PTFE, and thickness of the suture were identified as significant predictors of failure by univariate analysis. These variables were entered in a Cox regression model. Diabetes (HR 3.04, 95% CI 1.55-5.96, pZ0.001), but also a history of contralateral PTFE (HR 7.15, 95% CI 1.62-31.55, pZ0.009) and suture thickness (HR 5.58, 95% CI 1.64-18.90, pZ0.006) were found to be independent predictors of failure.
Predictors of failure with regard to secondary patency
With regard to secondary patency, again the same variables were assessed (Table 2) . Diabetes mellitus and mean operation time of the initial procedure were significant predictors of failure by univariate analysis. These variables, as well as the mean diameter of the cephalic vein at the level of the elbow (pZ0.095 by univariate analysis), were entered in a Cox regression model. Two factors could be identified as independent predictors of failure, i.e. diabetes (HR 4.15, 95% CI 1.64-10.54, pZ0.003) and mean operation time (HR 1.03, 95% CI 1.01-1.04, pZ0.0002).
Discussion
The 1-year primary and secondary patency rates of 54.7 and 79.2%, respectively, are in accordance with the results of others. [8] [9] [10] When compared with the survival rate of radiocephalic fistulas, as reported in a recent meta-analysis, 4 primary patency of the brachiocephalic fistulas in the present study is lower (54.7 versus 62.5%), while secondary patency rates are better (79.2 versus 66.0%). The figures mentioned in that meta-analysis corroborate our previously reported results with radiocephalic fistulas. 11, 12 With the aim of achieving better patency rates, a nurse practitioner especially dedicated to shunt care, a more meticulous work-up with preoperative Duplex scanning in each case, and the use of non-penetrating clips as a new anastomosing technique were recently introduced in our institution. Nevertheless, a careful selection of patients for a radiocephalic or brachiocephalic fistula seems of the utmost importance.
In the presented study cohort, the primary patency of brachiocephalic fistulas is somewhat lower than may be expected. Vessel sizes tend to be greater at the level of the elbow, in comparison to the wrist, and more easily accessible. On the other hand, steal phenomena may occur more frequently with an elbow fistula necessitating flow reducing salvage procedures or ligation of the fistula. In addition, the number of previously inserted central venous catheters for temporary use is probably higher in the group of patients with brachiocephalic fistulas, as this type of fistula was only used if a radiocephalic fistula had failed or was not feasible. However, by multivariate analysis a previous history of either subclavian or jugular catheters or ipsilateral radiocephalic fistulas did not influence graft patency. In our institution, 35.7% of patients are dialysed through a radiocephalic fistula, 30.1% through a brachiocephalic fistula, and 13.7% through a PTFE loop. The remaining patients use jugular catheters (8.2% tunnelled and 12.3% untunnelled, most of whom await further access surgery). Other autologous options at the level of the upper arm, though not performed in this study, include either transposition of the basilic vein or the distal cephalic vein.
Primary assisted and secondary patency rates in this study are, in our opinion, quite reasonable and compare favourably to those reported for radiocephalic fistulas. With PTAs and surgical revisions one is generally able to raise 1-year patency of radiocephalic fistulas from 62.5 to 66.0%. 4 In this study, revisions of brachiocephalic fistulas resulted in a primary patency of 54.7% compared to a secondary patency of 79.2%. We believe that greater venous diameters results in greater success after PTA and/or surgical revision. On the other hand, fistulas that failed because of steal syndrome may be associated with greater venous diameters at the level of the elbow and the upper arm. These parameters could, however, not be identified as distinct predictors for the occurrence of steal syndrome.
As previous radiocephalic fistulas do not influence patency rates of brachiocephalic fistulas, we feel the sequence of fistula operations should stay as recommended by the DOQI guidelines. Patients do profit from radiocephalic fistulas, despite patency rates that may be lower than expected, and vessels are preserved for future accesses. In this study, diabetes was found to have a negative influence on primary, primary assisted and secondary patency. The effect of diabetes may be even more prominent in radiocephalic fistulas, as demonstrated in several reports, including our previous study. 11, 13, 14 Diabetes affects peripheral arteries, such as the radial and ulnar artery, through medial sclerosis and endothelial cell dysfunction with subsequent impaired vasodilatation and hence stenosis. 15 From this study it appears that elbow sites are also affected by the same pathological mechanisms. In contrast, Murphy et al. 10 found no detrimental effect of diabetes on patency and complication rates in a series of 293 elbow fistulas. In their retrospective study, however, the diabetic group included a significant lower proportion of women and the numbers at risk had dropped considerably after 2 years of follow-up. The diabetic group in our study population had a significant higher BMI than the nondiabetic group (26.4 (5.4) versus 23.8 (3.6)). In the USA, controversy about the detrimental effects of diabetes had led to the preferential use of PTFE prostheses as the initial choice of permanent access in diabetics. 16 Although we have not investigated the results of PTFE loops in diabetics in the present study, there are several other reports suggesting that autologous fistulas perform better than PTFE loops. 17, 18 From the present study, it appears that PTAs and surgical revisions are less successful in diabetics. Patients with diabetes had smaller upper arm cephalic veins (4.2 versus 3.9 mm), but these two factors were not correlated with each other (pZ0.446), and the existence of a smaller venous outflow tract in itself was also identified to be an independent factor for failure with regard to secondary patency.
In conclusion, brachiocephalic fistulas seem to be a good alternative to radiocephalic fistulas with primary patency rates that are similar. Moreover, with brachiocephalic fistulas primary assisted and secondary patency rates are more favourable than reported for radiocephalic fistulas.
